Antithrombotic activity of a symmetrical triglyceride with eicosapentaenoic acid and gamma-linolenic acid in guinea pig mesenteric microvasculature. 1995

N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
Tsukuba Research Institute, Sandoz Pharmaceuticals LTD, Ibaraki, Japan.

The antithrombotic effect of a synthetic symmetrical triglyceride having eicosapentaenoic acid (EPA) at positions 1 and 3, and gamma-linolenic acid (GLA) at position 2 was investigated. Administration of the triglyceride significantly increased thrombus formation time and thrombotic occlusion time induced by light irradiation and a fluorescent dye in guinea pigs after 14 days administration compared to that of soybean oil. The antithrombotic effect of the triglyceride was similar to that of EPA ethyl ester. Administration of the triglyceride increased GLA, dihomo-gamma-linolenic acid (DGLA) and EPA contents in plasma and the liver, and the ratio of DGLA to arachidonic acid. These results might be responsible for this antithrombotic effect.

UI MeSH Term Description Entries
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008641 Mesenteric Vascular Occlusion Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6) Mesenteric Vascular Occlusions,Occlusion, Mesenteric Vascular,Occlusions, Mesenteric Vascular,Vascular Occlusion, Mesenteric,Vascular Occlusions, Mesenteric
D008643 Mesentery A layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves. Mesenteries
D010777 Photochemistry A branch of physical chemistry which studies chemical reactions, isomerization and physical behavior that may occur under the influence of visible and/or ultraviolet light. Photochemistries
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D005452 Fluoresceins A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. Tetraiodofluorescein

Related Publications

N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
August 1994, Prostaglandins, leukotrienes, and essential fatty acids,
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
October 1998, Aging (Milan, Italy),
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
December 1977, British medical journal,
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
September 2002, The Journal of surgical research,
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
January 1990, Nutrition (Burbank, Los Angeles County, Calif.),
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
June 1987, Lancet (London, England),
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
January 1980, Lancet (London, England),
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
December 1998, Clinical nutrition (Edinburgh, Scotland),
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
July 1985, Prostaglandins, leukotrienes, and medicine,
N Akahane, and S Ohba, and J Suzuki, and T Wakabayashi, and T Nakahara, and K Yanagi, and N Ohshima
January 1989, The American journal of physiology,
Copied contents to your clipboard!